FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1919-1920 June 26, 1997 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kupfer, D. J. PubMed Citation

To the Editor: In the excellent review of the management of insomnia by Kupfer and Reynolds (Jan. 30 issue),¹ we read that "zolpidem may be less likely than benzodiazepines . . . to cause cognitive and psychomotor side effects (and may have fewer withdrawal effects)." It is clear that many clinicians believe this to be true, since zolpidem is the most commonly prescribed hypnotic agent in the United States.² However, the authors cite only three studies in support of this idea, two of which did not even compare zolpidem with a benzodiazepine.

The study that did compare these drugs with . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.